The incidence of type 2 diabetes has increased dramatically in recent years, [11] [12] [13] and evidence-based treatment algorithms have encouraged the utilization of IT earlier in the course of the disease when glycemic control is inadequate. 14 More than half of all patients diagnosed with type 2 diabetes will require insulin for effective glucose management due to β-cell failure and the natural course of disease progression. 15 Therefore, any barrier to its use when indicated needs to be addressed to avoid a deleterious effect on long-term health. Psychological barriers can be complex and may at times seem insurmountable to patients, but providers are gradually developing evidence-based interventions designed to assist patients in overcoming such obstacles. Several studies aimed at exploring the complexity of PIR have heightened our awareness of its importance in clinical practice. However, easing the transition to IT when psychological barriers exist continues to challenge even the most experienced clinicians.
Brief Overview of the Literature
A review of the literature pertaining to patients' psychological barriers to starting insulin reveals common themes. PIR has been described as a constellation of psychosocial attitudes and beliefs, including fear of injections, pain, or side effects, such as hypoglycemia, feelings of personal failure, concern about not being able to handle the daily demands of an insulin regimen, perceptions about loss of control over one's life, and doubts about the actual benefit of using insulin. 6, 7, 16 To some, a recommendation to start IT triggers fears that his or her disease has or will become much worse, that they will be stigmatized, or that his or her lifestyle flexibility, quality of life, and relationships with family, friends, and co-workers will be adversely affected. 9, 10, 16 They may also feel that the need for insulin is somehow a reflection of personal failure in their disease self-management efforts. They may experience feelings of depression caused by a misperception of IT as 'the medication of last resort,' or may think of IT as punishment for not dieting or exercising enough. 10, 16, 17 A number of studies have described methods to screen for and/or measure PIR. In a multicity sample of 708 patients with type 2 diabetes who were not taking insulin, responses on a self-report survey showed that unwillingness to start IT if recommended was common (28.2%). 9 In this sample, unwillingness was more common in females (32%) than males (21.1%) and more common among ethnic minorities (35.1%) than non-Hispanic whites (22.4%). The most common negative attitudes toward insulin were patients thinking that IT would be permanent, restrictive, cause hypoglycemia, represent personal failure, and low self-efficacy. The belief that needing insulin would indicate failure to manage their diabetes was the most distinguishing factor between those who were willing versus unwilling.
In another study, a survey of 165 insulin-naïve patients with type 2 diabetes, more than 40% were not willing or only slightly willing to take insulin if advised. 18 Among the most frequent barriers were the belief that IT would be permanent (61.4%) and concern that IT would restrict their lives (50.6%).
Larkin et al. 16 reported similar results, and found that one-third of the patients surveyed would be unwilling to start IT if recommended.
Furthermore, higher levels of depression and poorer general health by selfreport were significantly correlated with increased resistance to IT.
Cultural differences may also influence the types of negative feelings associated with IT and have been noted in the literature. A qualitative study of 44 Mexican patients with type 2 diabetes revealed that their negative attitudes were focused on technical concerns about taking insulin, anxiety about pain, hypoglycemia, or perception that their disease had become worse, and that they have not been taking proper care of themselves. 19 In two studies that examined perceptions of social stigma and the influence on diabetes self-management in Chinese patients with type 2 diabetes, recurring themes included fear of losing their jobs, embarrassment about 
taking insulin in public, and concerns about discrimination due to their chronic illness. 20, 21 Two large multicenter trials have also reported negative patient attitudes toward the use of insulin. The United Kingdom Prospective Diabetes Study (UKPDS) showed that 27% of patients randomized to IT initially refused to take insulin. 10, 15 Resistance to IT among patients and providers was studied in the Diabetes Attitudes, Wishes, and Needs Study (DAWN). Data from surveys of patients with type 2 diabetes not taking insulin in 13 countries showed that patient resistance was substantial. Patients rated the clinical efficacy of insulin as low, and would blame themselves if they had to start IT. 
Using a Patient-centered Approach to Ease the Transition to Insulin Therapy
Once it becomes evident that a patient is experiencing undue distress, anxiety, or reluctance regarding a recommendation to start insulin, the use of a comprehensive patient-centered, knowledge-based, and coping-oriented approach is needed. The clinician should determine whether the barrier is it can supersede all other factors and may necessitate a referral for additional psychological support. However, true 'needle phobia' is rare and is amenable to expert therapy. 5, 10 Once the specific obstacles unique to each patient's experience have been identified, steps to overcome the barriers can be taken.
Specific strategies will differ depending on whether the factors identified require a knowledge-based or coping-oriented approach, or, as is extremely common, a combination of the two (see Table 1 ).
Summary
Psychological barriers to IT are commonly encountered in clinical practice.
These barriers are complex and require patience, understanding, and a multifaceted approach. Helping patients progress through the stages of anxious resistance to confident acceptance of a recommendation to start IT can be a challenging endeavor. Assessing the unique nature of each patient's resistance and determining whether the major cause is due to a knowledge deficit or is coping-oriented in nature enhances prioritization and direction of tailored interventions aimed at reducing resistance. Facilitating a quicker and less stressful transition to IT while providing the education and/or counseling needed to inform, empower, and equip patients to confidently manage the daily demands of IT is critical to achieving long-term health. Using a patientcentered, knowledge-based, and coping-oriented approach, while remembering that overcoming psychological barriers does not readily conform to a 'one size fits all' solution, is required. Overcoming PIR may take time, but in the process patients will regain control over their diabetes and achieve their personal treatment goals, rather than persisting in a defeated emotional state with subsequent deleterious impact on their capacity for diabetes self-management. ■ 
